Bio-Techne Corp
NASDAQ:TECH
| US |
|
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
| US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
| US |
|
Bank of America Corp
NYSE:BAC
|
Banking
|
| US |
|
Mastercard Inc
NYSE:MA
|
Technology
|
| US |
|
Abbvie Inc
NYSE:ABBV
|
Biotechnology
|
| US |
|
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
| US |
|
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
| US |
|
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
| US |
|
Visa Inc
NYSE:V
|
Technology
|
| CN |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
| US |
|
3M Co
NYSE:MMM
|
Industrial Conglomerates
|
| US |
|
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
| US |
|
Coca-Cola Co
NYSE:KO
|
Beverages
|
| US |
|
Realty Income Corp
NYSE:O
|
Real Estate
|
| US |
|
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
| US |
|
Walt Disney Co
NYSE:DIS
|
Media
|
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
This note will be permanently deleted.
Bio-Techne Corp
Bio-Techne Corp
Cash & Cash Equivalents
Bio-Techne Corp
Cash & Cash Equivalents Peer Comparison
TMO
DHR
MTD
A
IQV
Competitive Cash & Cash Equivalents Analysis
Latest Figures & CAGR of Competitors
| Company | Cash & Cash Equivalents | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
Bio-Techne Corp
NASDAQ:TECH
|
Cash & Cash Equivalents
$139.9m
|
CAGR 3-Years
-9%
|
CAGR 5-Years
8%
|
CAGR 10-Years
1%
|
|
|
Thermo Fisher Scientific Inc
NYSE:TMO
|
Cash & Cash Equivalents
$5.5B
|
CAGR 3-Years
-1%
|
CAGR 5-Years
38%
|
CAGR 10-Years
14%
|
|
|
Danaher Corp
NYSE:DHR
|
Cash & Cash Equivalents
$7B
|
CAGR 3-Years
4%
|
CAGR 5-Years
12%
|
CAGR 10-Years
8%
|
|
|
Mettler-Toledo International Inc
NYSE:MTD
|
Cash & Cash Equivalents
$70.2m
|
CAGR 3-Years
-13%
|
CAGR 5-Years
-11%
|
CAGR 10-Years
-5%
|
|
|
Agilent Technologies Inc
NYSE:A
|
Cash & Cash Equivalents
$1.7B
|
CAGR 3-Years
7%
|
CAGR 5-Years
-5%
|
CAGR 10-Years
-6%
|
|
|
IQVIA Holdings Inc
NYSE:IQV
|
Cash & Cash Equivalents
$1.4B
|
CAGR 3-Years
-14%
|
CAGR 5-Years
9%
|
CAGR 10-Years
7%
|
See Also
What is Bio-Techne Corp's Cash & Cash Equivalents?
Cash & Cash Equivalents
139.9m
USD
Based on the financial report for Mar 31, 2024, Bio-Techne Corp's Cash & Cash Equivalents amounts to 139.9m USD.
What is Bio-Techne Corp's Cash & Cash Equivalents growth rate?
Cash & Cash Equivalents CAGR 10Y
1%
Over the last year, the Cash & Cash Equivalents growth was 10%. The average annual Cash & Cash Equivalents growth rates for Bio-Techne Corp have been -9% over the past three years , 8% over the past five years , and 1% over the past ten years .
You don't have any saved screeners yet
